华邦健康：集采对公司影响有限，正大力发展零售市场和新药研发

Core Viewpoint - The impact of generic drug procurement on the company is relatively limited due to the slow progress of including topical medications in the procurement process, which provides a time window for strategic positioning [1] Group 1: Company Strategy - The company is actively promoting the consistency evaluation of generic drugs to optimize costs and processes [1] - The company is leveraging its advantages in the dermatological prescription market to significantly develop brand chain pharmacies and e-commerce channels, thereby increasing its retail market share [1] - The company continues to advance new drug research and development, rolling out 3-5 new product projects each year [1]